PDE4D and prostate carcinoma: In addition, overexpression of PDE4D was reported in human CRPC prostate adenocarcinoma samples in comparation with benign prostatic hyperplasia samples [11], and knockdown or inhibition of PDE4D reduces the growth of both CRPC prostate cancer cells in vitro and in vivo [11,19].